top of page
2023 Cancer Updates Website Background.png

From May through November 2023, Total Health hosted "Cancer Updates: A Dinner Series for Community Care Teams" at the Marriott Memphis East Hotel in Memphis, Tennessee.

The dinner series consisted of educational activities designed to meet the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of various cancers; including lung cancers, gastrointestinal cancers, breast cancers, genitourinary cancers, and hematological malignancies.

Each tumor-focused program agenda was comprised of multidisciplinary, case-based presentations that broke down the most clinically relevant information applicable to community care. These dinner programs were hosted as in-person events only.

Accreditation Information | 2.00

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Nurses (ANCC) Credit Designation

Amedco LLC designates this activity for a maximum of 2.00 ANCC contact hours.

 

Physicians (ACCME) Credit Designation

Amedco LLC designates this live activity for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 

Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

Amedco LLC designates this activity for a maximum of 2.00 knowledge-based CPE contact hours.


NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor. 

American Board of Internal Medicine (ABIM) MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.

Learning Objectives

  • Employ an understanding of personalized medicine to individualize the use of available drugs for lung cancers, gastrointestinal cancers, breast cancers, genitourinary cancers, and hematological malignancies.

  • Communicate the efficacy and safety of the drugs discussed in the case studies and other emerging treatments for lung cancers, gastrointestinal cancers, breast cancers, genitourinary cancers, and hematological malignancies.

  • Understand the emerging and standard diagnostic tests used to assist in planning therapy for lung cancers, gastrointestinal cancers, breast cancers, genitourinary cancers, and hematological malignancies.

  • Formulate management strategies, considering the contributory roles of local and systemic therapy.

  • Recall the design of ongoing clinical trials evaluating novel investigational agents and counsel appropriately selected patients about availability and participation.

Become an Exhibitor 

Follow for Updates

bottom of page